Ketteler, M., Martin, K. J., Cozzolino, M., Goldsmith, D., Sharma, A., Khan, S., . . . Audhya, P. (2012). Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: Study design and baseline characteristics of the IMPACT SHPT study. Nephrology, dialysis, transplantation, 27(5), 1942-1949. https://doi.org/10.1093/ndt/gfr531
Chicago Style (17th ed.) CitationKetteler, M., et al. "Paricalcitol Versus Cinacalcet Plus Low-dose Vitamin D for the Treatment of Secondary Hyperparathyroidism in Patients Receiving Haemodialysis: Study Design and Baseline Characteristics of the IMPACT SHPT Study." Nephrology, Dialysis, Transplantation 27, no. 5 (2012): 1942-1949. https://doi.org/10.1093/ndt/gfr531.
MLA (9th ed.) CitationKetteler, M., et al. "Paricalcitol Versus Cinacalcet Plus Low-dose Vitamin D for the Treatment of Secondary Hyperparathyroidism in Patients Receiving Haemodialysis: Study Design and Baseline Characteristics of the IMPACT SHPT Study." Nephrology, Dialysis, Transplantation, vol. 27, no. 5, 2012, pp. 1942-1949, https://doi.org/10.1093/ndt/gfr531.